Skip to search formSkip to main contentSkip to account menu

rizatriptan

Known as: rizatriptan [Chemical/Ingredient], Rizatriptán, N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Although triptans are widely used in the acute management of migraine, there is uncertainty around the comparative efficacy of… 
Review
2015
Review
2015
The study aims to provide an updated assessment of the evidence for individual pharmacological therapies for acute migraine… 
Highly Cited
2009
Highly Cited
2009
Objectives.— (1) To measure calcitonin gene‐related peptide (CGRP) levels in the saliva of individuals with migraine during the… 
Highly Cited
2008
Highly Cited
2008
Objective: To determine an effective and tolerable dose of a novel oral calcitonin gene-related peptide (CGRP) receptor… 
Review
2003
Review
2003
Background and Objectives.—Triptan use is associated with headache recurrence, and this has been cited as an important reason for… 
Review
2002
Review
2002
The triptans, selective serotonin 5-HT1B/1D agonists, are very effective acute migraine drugs. Soon, seven different triptans… 
Highly Cited
1998
Highly Cited
1998
Rizatriptan is a potent, oral, 5‐HT1B/1D agonist with more rapid absorption and higher bioavailability than oral sumatriptan. It… 
Highly Cited
1996
Highly Cited
1996
BACKGROUND Rizatriptan (MK-462) is a new 5-hydroxytryptamine1D (serotonin1D; 5-HT1D) receptor agonist for the acute treatment of…